Literature DB >> 29927573

Neuroprotective Effect of Tetrahedral DNA Nanostructures in a Cell Model of Alzheimer's Disease.

Xiaoru Shao1, Wenjuan Ma1, Xueping Xie1, Qianshun Li1, Shiyu Lin1, Tao Zhang1, Yunfeng Lin1.   

Abstract

Accumulating evidence supports the abnormal deposition of amyloid β-peptide (Aβ) as the main cause of Alzheimer's disease (AD). Therefore, fighting against the formation, deposition, and toxicity of Aβ is a basic strategy for the treatment of AD. In the process of in vitro nerve cell culture, screening out drugs that can antagonize a series of toxic reactions caused by β-amyloid deposition has become an effective method for the follow-up treatment of AD. Our previous studies showed that tetrahedral DNA nanostructures (TDNs) had good biocompatibility and had some positive effects on the biological behavior of cells. In this study, the main aim of our work was to explore the effects and potential mechanism of TDNs in protecting neuronal PC12 cells from the toxicity of Aβ. Our study demonstrated that TDNs can protect and rescue PC12 cell death through Aβ25-35-induced PC12 cell apoptosis. Further studies showed that TDNs significantly improved the apoptosis by affecting the abnormal cell cycle, restoring abnormal nuclear morphology and caspase activity. Western blot analysis showed that TDNs could prevent the damage caused by Aβ deposition by activating the ERK1/2 pathway and thus be a potential therapeutic agent with a neuroprotective effect in Alzheimer's disease. Our finding provides a potential application of TDNs in the prevention and treatment of AD.

Entities:  

Keywords:  Alzheimer’s disease; Aβ25−35; PC12 cells; nanomaterials; tetrahedral DNA nanostructures

Mesh:

Substances:

Year:  2018        PMID: 29927573     DOI: 10.1021/acsami.8b07827

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  12 in total

1.  Design, fabrication and applications of tetrahedral DNA nanostructure-based multifunctional complexes in drug delivery and biomedical treatment.

Authors:  Tao Zhang; Taoran Tian; Ronghui Zhou; Songhang Li; Wenjuan Ma; Yuxin Zhang; Nanxin Liu; Sirong Shi; Qianshun Li; Xueping Xie; Yichen Ge; Mengting Liu; Qi Zhang; Shiyu Lin; Xiaoxiao Cai; Yunfeng Lin
Journal:  Nat Protoc       Date:  2020-07-15       Impact factor: 13.491

2.  Silenced lncRNA H19 and up-regulated microRNA-129 accelerates viability and restrains apoptosis of PC12 cells induced by Aβ25-35 in a cellular model of Alzheimer's disease.

Authors:  Yan-Yun Zhang; Hai-Lan Bao; Li-Xia Dong; Yu Liu; Guo-Wei Zhang; Feng-Mao An
Journal:  Cell Cycle       Date:  2021-01-07       Impact factor: 4.534

3.  Potent anti-angiogenesis and anti-tumour activity of pegaptanib-loaded tetrahedral DNA nanostructure.

Authors:  Xueping Xie; Yuxin Zhang; Wenjuan Ma; Xiaoru Shao; Yuxi Zhan; Chenchen Mao; Bofeng Zhu; Yi Zhou; Hu Zhao; Xiaoxiao Cai
Journal:  Cell Prolif       Date:  2019-07-31       Impact factor: 6.831

4.  Treatment of Alzheimer's disease with framework nucleic acids.

Authors:  Xiaoru Shao; Weitong Cui; Xueping Xie; Wenjuan Ma; Yuxi Zhan; Yunfeng Lin
Journal:  Cell Prolif       Date:  2020-03-12       Impact factor: 6.831

5.  MicroRNA-214-3p modified tetrahedral framework nucleic acids target survivin to induce tumour cell apoptosis.

Authors:  Songhang Li; Yue Sun; Taoran Tian; Xin Qin; Shiyu Lin; Tao Zhang; Qi Zhang; Mi Zhou; Xiaolin Zhang; Yi Zhou; Hu Zhao; Bofeng Zhu; Xiaoxiao Cai
Journal:  Cell Prolif       Date:  2019-10-23       Impact factor: 6.831

6.  Effect of lncRNA WT1-AS regulating WT1 on oxidative stress injury and apoptosis of neurons in Alzheimer's disease via inhibition of the miR-375/SIX4 axis.

Authors:  Quanbao Wang; Xiumin Ge; Jie Zhang; Licheng Chen
Journal:  Aging (Albany NY)       Date:  2020-11-21       Impact factor: 5.682

Review 7.  Rationally Programming Nanomaterials with DNA for Biomedical Applications.

Authors:  Liangcan He; Jing Mu; Oleg Gang; Xiaoyuan Chen
Journal:  Adv Sci (Weinh)       Date:  2021-02-24       Impact factor: 16.806

Review 8.  Application of Programmable Tetrahedral Framework Nucleic Acid-Based Nanomaterials in Neurological Disorders: Progress and Prospects.

Authors:  Xingyu Chen; Yu Xie; Zhiqiang Liu; Yunfeng Lin
Journal:  Front Bioeng Biotechnol       Date:  2021-11-26

Review 9.  The biological applications of DNA nanomaterials: current challenges and future directions.

Authors:  Wenjuan Ma; Yuxi Zhan; Yuxin Zhang; Chenchen Mao; Xueping Xie; Yunfeng Lin
Journal:  Signal Transduct Target Ther       Date:  2021-10-08

10.  DNA Nanostructures in the Fight Against Infectious Diseases.

Authors:  David M Smith; Adrian Keller
Journal:  Adv Nanobiomed Res       Date:  2021-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.